Denosumab and bone metastasis-free survival in men with castrate-resistant prostate cancer - Subgroup analyses from an international, double-blind, randomized, phase 3 trial
Date issued
2011Journal title
EUROPEAN JOURNAL OF CANCER
Type of content
Publicación de congreso